Chemung Financial (CMHG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Achieved record quarterly net income of $9.2 million and EPS of $1.91 in Q1 2026, up 52.7% year-over-year, with strong momentum across business lines and stable credit quality.
Return on average equity rose to 14.25% and return on average assets to 1.36% for Q1 2026.
Growth was driven by higher net interest income, increased non-interest income, and lower provision for credit losses.
Strategic balance sheet restructuring and expansion into higher-growth markets like Albany and Buffalo, including opening a Buffalo office, are supporting growth.
Stable deposit base, ample liquidity, and high customer engagement across all geographies.
Financial highlights
Net interest income increased 19% year-over-year to $23.6 million, driven by higher loan balances and improved yields.
Net interest margin was 3.60%, up from 2.96% a year ago.
Non-interest income rose 7.3% to $6.3 million, led by wealth management and brokerage fee growth.
Non-interest expense increased 3.2% to $17.5 million, mainly due to higher compensation costs.
Annualized loan growth of 7.5% in Q1 2026; total loans reached $2.312 billion.
Outlook and guidance
Continued focus on loan growth in Albany and Buffalo, leveraging legacy market deposits and proceeds from balance sheet restructuring.
Management expects continued loan growth, especially in commercial real estate, and stable asset quality.
Pending charter conversion from New York trust company to a national bank.
Capital ratios remain well above regulatory minimums, supporting future growth and dividend capacity.
Well positioned for opportunistic acquisitions and scaling of wealth management, especially in Western New York.
Latest events from Chemung Financial
- Votes on directors, executive pay, and auditor ratification set for June 2026 meeting.CMHG
Proxy filing23 Apr 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with focus on governance.CMHG
Proxy filing23 Apr 2026 - Robust loan growth, margin expansion, and capital strength drive continued strategic momentum.CMHG
Investor presentation10 Apr 2026 - All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, equity plan, and auditor ratification.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025